indirubin has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, FD; Wu, GY | 1 |
| Damiens, E; Eisenbrand, G; Endicott, JA; Hoessel, R; Lawrie, A; Leclerc, S; Leost, M; Marie, D; Marko, D; Meijer, L; Niederberger, E; Nobel, ME; Tang, W; Tunnah, P | 1 |
2 other study(ies) available for indirubin and Leukemia L 1210
| Article | Year |
|---|---|
[Studies on the mechanism of indirubin action in the treatment of chronic granulocytic leukemia. II. Effects of indirubin on nucleic acid and protein synthesis in animal transplantable tumor cells and normal proliferating cells in vitro (author's transl)]
Topics: Animals; Cells, Cultured; DNA, Neoplasm; Indoles; Leukemia L1210; Leukemia, Myeloid; Neoplasm Proteins; Rats; RNA, Neoplasm | 1980 |
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cell Line; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; HL-60 Cells; Humans; Indigo Carmine; Indoles; Isatin; Jurkat Cells; K562 Cells; Leukemia L1210; Medicine, Chinese Traditional; Mice; Models, Molecular; Molecular Conformation; Protein Conformation; Protein Serine-Threonine Kinases; Recombinant Proteins; Spodoptera; Transfection | 1999 |